Reference
Gadolinium-based contrast agents for MRI: safety in pregnancy Internet Document : 15 Aug 2023. Available from: URL: https://www.fda.gov/drugs/regulatory-science-action/gadolinium-based-contrast-agents-mri-safety-pregnancy
Rights and permissions
About this article
Cite this article
In-utero GBCA-MRi exposure: no increased risk of fetal or neonatal death. Reactions Weekly 1971, 1 (2023). https://doi.org/10.1007/s40278-023-45126-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-45126-3